Literature DB >> 6897810

[Double deficiency of sulfite and xanthine oxidase causing encephalopathy and due to a hereditary anomaly in the metabolism of molybdenum].

H Ogier, J M Saudubray, C Charpentier, A Munnich, J L Perignon, A Kesseler, J Frezal.   

Abstract

The clinical features and biological results in a second patient with a metabolic defect of the molybdenum cofactor are described. The first case was reported in 1978 by Duran et al. Their clinical description was similar with early encephalopathy and myoclonial and dislocation of the lens. Biologically, this condition is characterised by secondary hypo-uricemia and hypo-uricuria due to xanthine oxidase deficiency and by sulphituria, resulting from sulphite oxidase deficiency. These two enzymes have a common hepatic molybdenum cofactor, the structure and metabolism of which are only partially known.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6897810

Source DB:  PubMed          Journal:  Ann Med Interne (Paris)        ISSN: 0003-410X


  3 in total

1.  Anatomo-pathological findings in a case of combined deficiency of sulphite oxidase and xanthine oxidase with a defect of molybdenum cofactor.

Authors:  A Roth; C Nogues; J P Monnet; H Ogier; J M Saudubray
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

2.  Report on a new patient with combined deficiencies of sulphite oxidase and xanthine dehydrogenase due to molybdenum cofactor deficiency.

Authors:  W Endres; Y S Shin; R Günther; H Ibel; M Duran; S K Wadman
Journal:  Eur J Pediatr       Date:  1988-12       Impact factor: 3.183

3.  Molybdenum cofactor biosynthesis in humans. Identification of two complementation groups of cofactor-deficient patients and preliminary characterization of a diffusible molybdopterin precursor.

Authors:  J L Johnson; M M Wuebbens; R Mandell; V E Shih
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.